Showing 3691-3700 of 5956 results for "".
- Bausch + Lomb Retina News, Eventshttps://modernod.com/news/bausch-lomb-retina-news-events/2480011/In advance of this week’s ASRS meeting, Bausch + Lomb Vice President and general manager of Surgical, Chuck Hess, distributed a customer letter to surgeons providing them an update on our progress in retina. The letter is below: Dear Eye Care Professional: At this time last y
- EyeSouth Partners Develops of Physician Advisory Boardhttps://modernod.com/news/eyesouth-partners-develops-of-physician-advisory-board/2480041/As part of its continuing focus on the highest quality patient outcomes, EyeSouth Partners, a network of integrated eye care practices located throughout the Southeast, announced the formation of its physician advisory board. Its responsibilities will include overseeing clinical policies and proc
- Alcon to Showcase New Products, Commitment to ECP Education at 2018 Optometry’s Meetinghttps://modernod.com/news/alcon-to-showcase-new-products-commitment-to-ecp-education-at-2018-optometrys-meeting/2480083/Alcon will introduce new products and educational resources to eye care professional (ECP) and paraoptometric audiences at this year’s American Optometric Association (AOA) Optometry’s Meeting taking place June 20-24 in Denver. Notably, Leatrice Eiseman, executive director at the Pantone C
- Allergan Announces Former Abbott Executive to Join Board of Directors as Part of “Refreshment Process”https://modernod.com/news/allergan-announces-former-abbott-executive-to-join-board-of-directors-as-part-of-refreshment-process/2480087/Allergan on Thursday said that former Abbott Laboratories executive Thomas Freyman will be joining its board with immediate effect. CEO Brent Saunders remarked “[Freyman] has nearly four decades of industry experience including finance leadership and serving on multiple public boards, makin
- Group of Takeda Shareholders Call Proposed Shire Purchase “Height of Madness”https://modernod.com/news/group-of-takeda-shareholders-call-proposed-shire-purchase-height-of-madness/2480115/A group of Takeda shareholders have criticized the company’s deal to buy Shire as “the height of madness,” raising concerns over the level of debt that will need to be taken on to fund the purchase, the Financial Times reported. The group hold just over 1 percent of Takeda’
- Orasis Pharmaceuticals Closes $13 Million Series B Financinghttps://modernod.com/news/orasis-pharmaceuticals-closes-13-million-series-b-financing/2480119/Privately-held Orasis Pharmaceuticals announced the closing of a $13 million Series B financing to be used to advance Orasis’s lead product candidate, CSF-1, an eye drop being developed for the treatment of presbyopia symptoms, through completion of its phase 2b clinical trial. The proceeds will
- Caution Needed With Artificial Intelligence in Medicine, Experts Warnhttps://modernod.com/news/caution-needed-with-artificial-intelligence-in-medicine-experts-warn/2480125/Current hype surrounding machine learning and artificial intelligence (AI) in medicine is enormous, with seemingly daily headlines declaring that some new model will change how a disease is diagnosed or treated. Experts are more cautious, though, with several speakers at the recent
- Miracles in Sight Seeks to Expand Adoption of Innovative Surgery With Prepared DMEK Graftshttps://modernod.com/news/miracles-in-sight-seeks-to-expand-adoption-of-innovative-surgery-with-prepared-dmek-grafts/2480128/Across the world, Descemet Membrane Endothelial Keratoplasty (DMEK) is becoming the standard of care for endothelial dysfunction. Miracles In Sight (MIS), a nonprofit eye bank that recovers, processes, and distributes ocular tissue, is helping reduce the learning curve for this new surgical techn
- Rayner Receives CE Mark for Its Hydrophobic Fully Preloaded IOL Injection Systemhttps://modernod.com/news/rayner-receives-ce-mark-for-its-hydrophobic-fully-preloaded-iol-injection-system/2480142/Rayner has received European CE Mark for its first hydrophobic fully preloaded IOL injection system. The RayOne Hydrophobic IOL is made of a new proprietary material that is glistening-free, with a patented “Cornerstone” lens shape for stability during lens delivery and post-implantat
- Researchers Identify Genetic Variants that May Predict Glaucoma Riskhttps://modernod.com/news/researchers-identify-genetic-variants-that-may-predict-glaucoma-risk/2480146/A study led by scientists from King’s College London, University College London, Massachusetts Eye and Ear, and Harvard Medical School has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness.